New FDA registrations for pjur

25.09.2014 | Wasserbillig, Luxembourg – In pjur group’s consistent mission of quality and integrity, the Quality Management division of the pjur group under the direction of Patrick Giebel, QM Representative and CFO at pjur group, has successfully completed additional registrations with the US FDA (Food and Drug Administration). The entire registration process was completed in just six months due to sound data and excellence in preparation. pjur group received its “Clearance Letter” – the official confirmation letter from the FDA – in July.

With the introduction of polyisoprene and polyurethane condoms, the FDA revised and expanded the registration standards and tests required for personal lubricants. Hence with the latest approvals, pjur’s own formulations meet the new standards by the FDA.This again validates the pjur_and_FDA quality standards of pjur products, considering the strict requirements of the American supervisory authority which are respected and recognized worldwide.
Additional registrations with the Thai FDA were successfully concluded concurrent with the confirmations in the USA. The pjur group received the corresponding confirmation from the local supervisory authority last week. With this confirmation, the pjur group is one of the few companies which can sell personal lubricants registered by the Thai FDA in Thailand.
“Completing the registrations in the USA and Thailand within such a short period is an immense success for our company and presents a unique selling opportunity for us. Consumers in the US are following government approvals and compliance more and more as are consumers worldwide. We will benefit greatly from these new seals of approval, again showing the market we are one of highest quality lubricant brands”, says Patrick Giebel.
Detailed information on pjur can also be found at